Tapewire

Nasdaq · USD

VSTM

Verastem, Inc.

Export transactions ↓
Tapewire entity
5242
SEC CIK
0001526119
Parsed reports
312

Last 12 months

Inside the activity.

0 purchase rows · 33 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202509
Dec 2025013
Jan 202602
Feb 202601
Mar 202600
Apr 202600
May 202601
Jun 202603
Jul 202600
Aug 202601
Sep 202601
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 19, 2024 Filed Mar 20, 2024 21:36 UTC SaleCommon Stock 130 $10.38 $1,349.40
Disclosure

SEC source: 0001104659-24-036792 · tm249354-3_4seq1.xml · nonDerivative · entry 2

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,391

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 19, 2024 Filed Mar 20, 2024 21:34 UTC
Paterson DanDirector · President and CEO
SaleCommon Stock 182 $10.38 $1,889.16
Disclosure

SEC source: 0001104659-24-036790 · tm249354-2_4seq1.xml · nonDerivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,490

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 18, 2024 Filed Mar 20, 2024 21:32 UTC SaleCommon Stock 537 $10.71 $5,751.27
Disclosure

SEC source: 0001104659-24-036787 · tm249354-1_4seq1.xml · nonDerivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 89,913

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 18, 2024 Filed Mar 20, 2024 21:36 UTC SaleCommon Stock 283 $10.71 $3,030.93
Disclosure

SEC source: 0001104659-24-036792 · tm249354-3_4seq1.xml · nonDerivative · entry 1

Gagnon Robert E. · CIK 0001504983 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,521

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 18, 2024 Filed Mar 20, 2024 21:34 UTC
Paterson DanDirector · President and CEO
SaleCommon Stock 244 $10.71 $2,613.24
Disclosure

SEC source: 0001104659-24-036790 · tm249354-2_4seq1.xml · nonDerivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 86,672

F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:10 UTC GrantStock Option (right to buy) · Derivative 5,291 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034035 · tm248737-2_4seq1.xml · derivative · entry 2

ROBERTSON MICHELLE · CIK 0001755098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,291

Underlying: Common Stock · 5,291 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:10 UTC Disposition to issuerStock Option (right to buy) · Derivative 5,291 Not disclosed Strike: $37.32 Not disclosed
Disclosure

SEC source: 0001104659-24-034035 · tm248737-2_4seq1.xml · derivative · entry 1

ROBERTSON MICHELLE · CIK 0001755098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,291 shares

Expires 2031-11-15

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 5,291 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F2 · derivative.exercise_date: The canceled stock option was granted on November 15, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from November 2021 to October 2022.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:17 UTC GrantStock Option (right to buy) · Derivative 11,865 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034044 · tm248737-7_4seq1.xml · derivative · entry 3

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,865

Underlying: Common Stock · 11,865 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 7,699 Not disclosed Strike: $21.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034044 · tm248737-7_4seq1.xml · derivative · entry 2

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2029-06-21

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F3 · derivative.exercise_date: The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:17 UTC Disposition to issuerStock Option (right to buy) · Derivative 4,166 Not disclosed Strike: $59.04 Not disclosed
Disclosure

SEC source: 0001104659-24-034044 · tm248737-7_4seq1.xml · derivative · entry 1

Stuglik Brian M · CIK 0001716328 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,157 shares

Expires 2028-06-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F2 · derivative.exercise_date: The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on October 2, 2017 ending on September 2, 2018.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:14 UTC
JOHNSON JOHNDirector
GrantStock Option (right to buy) · Derivative 8,549 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 5

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,549

Underlying: Common Stock · 8,549 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:14 UTC
JOHNSON JOHNDirector
Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $49.92 Not disclosed
Disclosure

SEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 4

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2031-06-28

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F5 · derivative.exercise_date: The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:14 UTC
JOHNSON JOHNDirector
Disposition to issuerStock Option (right to buy) · Derivative 2,300 Not disclosed Strike: $21.24 Not disclosed
Disclosure

SEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 3

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,300 shares

Expires 2030-06-16

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F4 · derivative.exercise_date: The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:14 UTC
JOHNSON JOHNDirector
Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $21.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 2

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2030-04-29

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F3 · derivative.exercise_date: The canceled stock option was granted on April 29, 2020 and provided for vesting in twelve equal monthly beginning on May 29, 2020 and ending on April 29, 2021.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:14 UTC
JOHNSON JOHNDirector
Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $15.60 Not disclosed
Disclosure

SEC source: 0001104659-24-034041 · tm248737-5_4seq1.xml · derivative · entry 1

JOHNSON JOHN · CIK 0001410781 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2030-01-03

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange,the Reporting Person received a grant of 8,549 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F2 · derivative.exercise_date: The canceled stock option was granted on January 3, 2020 and provided for cliff vesting on June 3, 2021.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:16 UTC GrantStock Option (right to buy) · Derivative 12,572 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 6

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,572

Underlying: Common Stock · 12,572 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:16 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $49.92 Not disclosed
Disclosure

SEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 5

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2031-06-28

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F6 · derivative.exercise_date: The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:16 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $21.24 Not disclosed
Disclosure

SEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 4

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2030-06-16

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F5 · derivative.exercise_date: The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:16 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $21.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 3

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2029-06-21

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F4 · derivative.exercise_date: The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:16 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,157 Not disclosed Strike: $67.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 2

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,157 shares

Expires 2028-06-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F3 · derivative.exercise_date: The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on July 11, 2018 ending on June 11, 2019.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:16 UTC Disposition to issuerStock Option (right to buy) · Derivative 4,166 Not disclosed Strike: $25.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034043 · tm248737-6_4seq1.xml · derivative · entry 1

Rowinsky Eric K · CIK 0001318886 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,166 shares

Expires 2027-06-13

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 12,572 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F2 · derivative.exercise_date: The canceled stock option was granted on June 13, 2017 and provided for vesting in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC GrantStock Option (right to buy) · Derivative 16,078 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 9

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,078

Underlying: Common Stock · 16,078 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $49.92 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 8

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2031-06-28

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F9 · derivative.exercise_date: The canceled stock option was granted on June 28, 2021 and provided for vesting in twelve equal month installments beginning on the on the last day of each month over a period from June 2021 to May 2022.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $21.24 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 7

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2030-06-16

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F8 · derivative.exercise_date: The canceled stock option was granted on June 16, 2020 and provided for vesting in twelve equal monthly installments beginning on June 30, 2020 and ending on May 31, 2021.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $21.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 6

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2029-06-21

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F7 · derivative.exercise_date: The canceled stock option was granted on June 21, 2019 and provided for vesting in twelve equal monthly installments beginning on July 21, 2019 and ending on June 21, 2020.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $67.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 5

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2028-06-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F6 · derivative.exercise_date: The canceled stock option was granted on June 21, 2018 and provided for vesting in twelve equal monthly installments beginning on July 11, 2018 ending on June 11, 2019.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $25.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 4

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2027-06-13

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F5 · derivative.exercise_date: The canceled stock option was granted on June 13, 2017 and provided for vesting in twelve monthly installments through June 13, 2018, with the first monthly installment vesting on July 13, 2017.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $16.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 3

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2026-06-13

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F4 · derivative.exercise_date: The canceled stock option was granted on June 14, 2016 and provided for vesting in twelve monthly installments through June 14, 2017, with the first monthly installment vesting on July 14, 2016.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 1,497 Not disclosed Strike: $95.88 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 2

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,497 shares

Expires 2025-06-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F3 · derivative.exercise_date: The canceled stock option was granted on June 12, 2015 and provided for vesting in twelve monthly installments through June 12, 2016, with the first monthly installment vesting on July 12, 2015.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:07 UTC Disposition to issuerStock Option (right to buy) · Derivative 2,083 Not disclosed Strike: $120.84 Not disclosed
Disclosure

SEC source: 0001104659-24-034034 · tm248737-1_4seq1.xml · derivative · entry 1

Kauffman Michael · CIK 0001364719 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,083 shares

Expires 2024-06-10

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 16,078 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F2 · derivative.exercise_date: The canceled stock option was granted on June 10, 2014 and provided for vesting in twelve equal monthly installments from June 10, 2014 until June 10, 2015.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:18 UTC
Bunn Paul A.Director
GrantStock Option (right to buy) · Derivative 6,113 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034045 · tm248737-8_4seq1.xml · derivative · entry 2

Bunn Paul A. · CIK 0001868760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,113

Underlying: Common Stock · 6,113 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 6,113 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F1 · derivative.exercise_date: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 6,113 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:18 UTC
Bunn Paul A.Director
Disposition to issuerStock Option (right to buy) · Derivative 6,113 Not disclosed Strike: $53.16 Not disclosed
Disclosure

SEC source: 0001104659-24-034045 · tm248737-8_4seq1.xml · derivative · entry 1

Bunn Paul A. · CIK 0001868760 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,113 shares

Expires 2031-06-24

F1 · price: On March 11, 2024, the Issuer cancelled, pursuant to the Issuer's option exchange program, certain eligible unexercised options with an exercise price greater than $15.00 granted to the Reporting Person. In exchange, the Reporting Person received a grant of 6,113 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (with the number of shares vesting on each vesting date will be rounded down to the nearest whole share, except with respect to the vesting dates on which all remaining unvested shares shall vest), provided the Reporting Person continues to serve as a director of or other service provider to the Issuer on each such vesting date.

F2 · derivative.exercise_date: The canceled stock option was granted on June 24, 2021, and provided for vesting in twelve equal month installments beginning on the last day of each month over a period from June 2021 to May 2022.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
GrantStock Option (right to buy) · Derivative 23,843 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 14

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,843

Underlying: Common Stock · 23,843 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
GrantStock Option (right to buy) · Derivative 144,137 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 13

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,137

Underlying: Common Stock · 144,137 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 30,708 Not disclosed Strike: $28.32 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 12

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,708 shares

Expires 2031-01-04

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F13 · derivative.exercise_date: The canceled option was granted on December 15, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 33,962 Not disclosed Strike: $26.40 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 11

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 33,962 shares

Expires 2030-12-18

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F12 · derivative.exercise_date: The canceled option was granted on December 18, 2020 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 12,500 Not disclosed Strike: $16.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 10

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2029-12-13

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F11 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 16,666 Not disclosed Strike: $16.08 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 9

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 16,666 shares

Expires 2029-12-13

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F10 · derivative.exercise_date: The canceled option was granted on December 13, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and vesting as to 12.5% of the shares underlying the option at the end of each successive three-month period following the first anniversary of grant date until the second anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 20,832 Not disclosed Strike: $21.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 8

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 20,832 shares

Expires 2029-06-21

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F9 · derivative.exercise_date: The canceled option was granted on June 21, 2019 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 12.5% of the shares underlying the option on each successive three month period after such date until the second anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 6,250 Not disclosed Strike: $42.12 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 7

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,250 shares

Expires 2029-01-03

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F8 · derivative.exercise_date: The canceled option was granted on January 3, 2019 and provided for vesting as to 25% of the shares underlying the option on January 1, 2020 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2023.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 3,750 Not disclosed Strike: $35.64 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 6

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,750 shares

Expires 2028-01-05

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F7 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting based on the achievement of certain performance milestones which were met by June 30, 2018 and by March 31, 2019.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 6,249 Not disclosed Strike: $35.64 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 5

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,249 shares

Expires 2028-01-05

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F6 · derivative.exercise_date: The canceled option was granted on January 5, 2018 and provided for vesting as to 25% of the shares underlying the option on January 1, 2019 and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until January 1, 2022.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 8,333 Not disclosed Strike: $16.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 4

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,333 shares

Expires 2026-06-13

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F5 · derivative.exercise_date: The canceled option was granted on June 14, 2016 and provided for vesting as to 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in June 2017, and vesting as to the remaining 50% of the shares underlying the option upon satisfaction of a certain performance milestone met in September 2017.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 5,500 Not disclosed Strike: $22.32 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 3

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,500 shares

Expires 2025-12-31

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F4 · derivative.exercise_date: The canceled option was granted on January 1, 2016 and provided for vesting as to 50% of the shares underlying the option on November 9, 2016, and vesting as to the remaining 50% of the shares underlying the option on November 9, 2017.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 11,166 Not disclosed Strike: $25.56 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 2

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 11,166 shares

Expires 2025-11-08

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F3 · derivative.exercise_date: The canceled option was granted on November 9, 2015 and provided for vesting as to 50% of the shares underlying the option on the first anniversary of the grant date, and vesting as to the remaining 50% of the shares underlying the option on the second anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:12 UTC
Paterson DanDirector · President and CEO
Disposition to issuerStock Option (right to buy) · Derivative 12,064 Not disclosed Strike: $110.28 Not disclosed
Disclosure

SEC source: 0001104659-24-034039 · tm248737-4_4seq1.xml · derivative · entry 1

Paterson Dan · CIK 0001563202 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,064 shares

Expires 2025-01-08

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 144,137 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 23,843 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F2 · derivative.exercise_date: The canceled option was granted on January 8, 2015 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period following the first anniversary of the grant date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
GrantStock Option (right to buy) · Derivative 1,175 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 8

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,175

Underlying: Common Stock · 1,175 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
GrantStock Option (right to buy) · Derivative 5,413 Not disclosed Strike: $11.44 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 7

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,413

Underlying: Common Stock · 5,413 shares

Expires 2034-03-11

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F1 · derivative.exercise_date: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
Disposition to issuerStock Option (right to buy) · Derivative 1,875 Not disclosed Strike: $27.72 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 6

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,875 shares

Expires 2031-12-23

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F7 · derivative.exercise_date: The canceled option was granted on December 23, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date.

Read SEC document
March 11, 2024 Filed Mar 13, 2024 22:11 UTC
Calkins DanielChief Financial Officer
Disposition to issuerStock Option (right to buy) · Derivative 750 Not disclosed Strike: $26.40 Not disclosed
Disclosure

SEC source: 0001104659-24-034037 · tm248737-3_4seq1.xml · derivative · entry 5

Calkins Daniel · CIK 0001951861 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 750 shares

Expires 2031-01-04

F1 · price: On March 11, 2024, pursuant to the Issuer's option exchange program, the Issuer canceled certain eligible unexercised options granted to the Reporting Person with an exercise price greater than $15. In exchange, the Reporting Person received (i) in the case of the canceled options that were fully vested as of March 8, 2024, a grant of 5,413 stock options that will vest in two equal installments over a two-year period from March 11, 2024 (the "Grant Date") and (ii) in the case of the canceled options there were unvested as of March 8, 2024, a grant of 1,175 stock options that will vest as to 25% on the first anniversary of the Grant Date and as to an additional 6.25% at the end of each successive three-month period following the first anniversary of the Grant Date until the fourth anniversary of the Grant Date, subject to the Reporting Person's continued service to the Issuer on the vesting date.

F6 · derivative.exercise_date: The canceled option was granted on January 4, 2021 and provided for vesting as to 25% of the shares underlying the option on the first anniversary of the grant date and, thereafter, vesting as to 6.25% of the shares underlying the option at the end of each successive three-month period after such date until the fourth anniversary of the grant date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.